688222 Share Price | HitGen, Inc. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor Management Efficiency with a low ROCE of 3.70%

The company has been able to generate a Return on Capital Employed (avg) of 3.70% signifying low profitability per unit of total capital (equity and debt)

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 16.68% and Operating profit at 27.97% over the last 5 years

The company has declared Positive results for the last 5 consecutive quarters

With ROE of 9.11%, it has a very expensive valuation with a 7.95 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 15,382 Million (Large Cap)

P/E

87.00

Industry P/E

Dividend Yield

0.34%

Debt Equity

-0.48

Return on Equity

9.11%

Price to Book

10.00

Revenue and Profits:

Net Sales:

185 Million

(Quarterly Results - Jun 2026)

Net Profit:

38 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

49.71%

6 Months

102.73%

1 Year

92.23%

2 Years

439.51%

3 Years

204.77%

4 Years

167.09%

5 Years

63.77%

HitGen, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

16.68%

EBIT Growth (5y)

27.97%

EBIT to Interest (avg)

2.58

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

0.27

Tax Ratio

8.13%

Dividend Payout Ratio

47.57%

Pledged Shares

Institutional Holding

ROCE (avg)

6.24%

ROE (avg)

4.35%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.95

EV to EBIT

87.26

EV to EBITDA

66.19

EV to Capital Employed

14.43

EV to Sales

19.83

PEG Ratio

1.17

Dividend Yield

0.43%

ROCE (Latest)

16.54%

ROE (Latest)

9.11%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 54.11% vs 37.80% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 73.85% vs 573.91% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "185.40",
          "val2": "120.30",
          "chgp": "54.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "55.30",
          "val2": "42.40",
          "chgp": "30.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.80",
          "val2": "2.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "-14.30",
          "chgp": "95.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.90",
          "val2": "21.80",
          "chgp": "73.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "219.40%",
          "val2": "215.60%",
          "chgp": "0.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 23.09% vs 16.19% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 120.64% vs 22.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "525.60",
          "val2": "427.00",
          "chgp": "23.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "166.90",
          "val2": "116.60",
          "chgp": "43.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.60",
          "val2": "13.10",
          "chgp": "-11.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-21.60",
          "val2": "-38.70",
          "chgp": "44.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "110.10",
          "val2": "49.90",
          "chgp": "120.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "206.60%",
          "val2": "142.40%",
          "chgp": "6.42%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]